Effects of Branched-Chain-Enriched Amino Acid Solution on Insulin and Glucagon Secretion and Blood Glucose Level in Liver Cirrhosis

References

• Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalized of plasma amino acids on hepatic encephalopathy in man. Surgery 1976;80:77–91.
   PubMed Web of Science ®Google Scholar
• Morioka S, Kanai K, Kato M, Nakajima T, Yoshimi T, Masaka M, et al. Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy. Gastroenterol Jpn 1983;18:553–9.
   PubMedGoogle Scholar
• Maddrey WC. Branched chain amino acid therapy in liver disease. J Am Coll Nutr 1985;4:639–50.
   PubMed Web of Science ®Google Scholar
• Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966;45:1487–502.
   Google Scholar
• Ohneda A, Aguilar-Parada E, Eisentraut AM, Unger RH. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. J Clin Invest 1968;47:2305–22.
   PubMed Web of Science ®Google Scholar
• Rocha DM, Faloona GR, Unger RH. Glucagon-stimulating activity of 20 amino acids in dogs. J Clin Invest 1972;51: 2346–51.
   Google Scholar
• Kuhara T, Ikeda S, Ohneda A, Sasaki Y. Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. Am J Physiol 1991;260:E21–6.
   PubMed Web of Science ®Google Scholar
• Otsuki M, Sakamoto C, Hosi Y, Maeda M, Morita S, Ohki A, et al. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. J Clin Invest 1979;63:478–84.
   PubMedGoogle Scholar
• Sorenson RL, Elde RP. Dissociation of glucose stimulation of somatostatin and insulin release from glucose inhibition of glucagon release in the isolated perfused rat pancreas. Diabetes 1983;32:561–7.
   PubMedGoogle Scholar
• Unger RH. Glucagon and insulin:glucagon ratio in diabetes and other catabolic illness. Diabetes 1971;20:834–8.
   PubMed Web of Science ®Google Scholar
• Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967;2:1051–5.
   Google Scholar
• Petrides AS, De-Fronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabet Metab Rev 1989;5:691–709.
   PubMedGoogle Scholar
• Petrides AS, Schulze-Berge D, Vogt C, Matthews S, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993;18:284–91.
   PubMedGoogle Scholar
• Gentile S, Loguercio C, Marmo R, Carbone L, Del-Vecchio-Blanco C. Incidence of altered glucose tolerance in liver cirrhosis. Diabet Res Clin Pract 1993;22:37–44.
   PubMedGoogle Scholar
• Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616–27.
   Google Scholar
• Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabet 1995;103:63–74.
   PubMed Web of Science ®Google Scholar
• Uemura K, Sakato M, Miyahara H, Takei M, Akou S, Yanagisawa Y, et al. A case of liver cirrhosis with portal calcification associated with hypoglycemia induced by branched chain amino acid solution. Jpn J Gastroenterol 1993;90:2127–31 (in Japanese).
   Google Scholar
• Pugh RNH, Murray-Layon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Willams R. Plasma and brain amino acids in fluminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976;10:387–94.
   Google Scholar
• Morgan MY. Branched chain amino acids in the management of chronic liver disease. Facts and fantasies. J Hepatol 1990;11: 133–41.
   PubMedGoogle Scholar
• Sanjo K, Yamasaki M. Early phase II study of MHS-2; amino acids solution for hepatic encephalopathy. Pharmacol Ther 1991;19:195–206 (in Japanese).
   Google Scholar
• Watanabe A, Hayashi S, Shiota T, Nagashima H. Comparative study of amino acid, ammonia and pancreatic hormone levels in the blood of cirrhotic patients following intravenous administration of a branched-chain amino acid-enriched solution. Acta Med Okayama 1983;37:441–5.
   PubMedGoogle Scholar
• Parrilla R, Goodman MN, Toews CJ. Effect of glucagon: insulin ratios on hepatic metabolism. Diabetes 1974;23:725–31.
   Google Scholar
• Müller MJ, Willmann O, Rieger A, Fenk A, Selberg O, Lautz HU, et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 1992;102:2033–41.
   Google Scholar
• Chen M, Bergman RN, Porte D Jr. Insulin resistance and betacell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 1988;67:951–7.
   Google Scholar
• Pagano G, Marena S, Scaglione L, Bodoni P, Montegrosso G, Bruno A, et al. Insulin resistance shows selective metabolic and hormonal targets in elderly. Eur J Clin Invest 1996;26:650–6.
   PubMedGoogle Scholar
• Silva G, Gomis R, Bosch J, Casamitjana R, Mastai R, Navasa M, et al. Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels. J Hepatol 1988;6:325–31.
   Google Scholar
• Keller U, Sonnoenberg GE, Burckhardt D, Perruchoud A. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver. J Clin Endocrinol Metab 1982;54:961–8.
   PubMedGoogle Scholar
• Petrides AS, De-Fronzo RA. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis. Metabolism 1994;43:85–9.
   PubMedGoogle Scholar